Gaofeng Liang

3.6k total citations · 1 hit paper
118 papers, 2.7k citations indexed

About

Gaofeng Liang is a scholar working on Molecular Biology, Cancer Research and Biomedical Engineering. According to data from OpenAlex, Gaofeng Liang has authored 118 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Molecular Biology, 28 papers in Cancer Research and 27 papers in Biomedical Engineering. Recurrent topics in Gaofeng Liang's work include MicroRNA in disease regulation (26 papers), Advanced biosensing and bioanalysis techniques (19 papers) and Nanoplatforms for cancer theranostics (16 papers). Gaofeng Liang is often cited by papers focused on MicroRNA in disease regulation (26 papers), Advanced biosensing and bioanalysis techniques (19 papers) and Nanoplatforms for cancer theranostics (16 papers). Gaofeng Liang collaborates with scholars based in China, United States and Australia. Gaofeng Liang's co-authors include Yanliang Zhu, Zhongdang Xiao, Wenpo Feng, Aihua Jing, Baoan Chen, Shegan Gao, Ke Si, Doulathunnisa Jaffar Ali, Tian Tian and Bo Sun and has published in prestigious journals such as Advanced Materials, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Gaofeng Liang

114 papers receiving 2.7k citations

Hit Papers

Engineered exosomes for targeted co-delivery of miR-21 in... 2020 2026 2022 2024 2020 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer
    2020 536 citations Gaofeng Liang, Yanliang Zhu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gaofeng Liang China 25 1.6k 935 603 405 268 118 2.7k
Ningning Yang China 21 1.6k 1.0× 856 0.9× 443 0.7× 212 0.5× 240 0.9× 71 2.6k
Xiaohui Zhu China 27 1.4k 0.9× 743 0.8× 708 1.2× 695 1.7× 128 0.5× 88 2.9k
Keivan Majidzadeh‐A Iran 29 1.3k 0.8× 481 0.5× 604 1.0× 180 0.4× 165 0.6× 149 2.7k
Yunsheng Xu China 27 1.1k 0.7× 351 0.4× 685 1.1× 299 0.7× 305 1.1× 70 2.6k
Xuan Liu China 30 1.6k 1.0× 652 0.7× 497 0.8× 276 0.7× 303 1.1× 110 2.8k
Zhiming Li China 33 1.6k 1.0× 422 0.5× 591 1.0× 589 1.5× 144 0.5× 123 3.2k
Bao‐Ting Zhang Hong Kong 32 2.1k 1.3× 359 0.4× 624 1.0× 212 0.5× 106 0.4× 65 2.9k
Hualin Fu China 26 889 0.6× 316 0.3× 561 0.9× 481 1.2× 231 0.9× 46 1.9k
Qilong Wang China 25 1.1k 0.7× 518 0.6× 224 0.4× 191 0.5× 278 1.0× 73 1.8k
Jinhua Zhou China 33 1.0k 0.6× 579 0.6× 402 0.7× 394 1.0× 208 0.8× 124 2.8k

Countries citing papers authored by Gaofeng Liang

Since Specialization
Citations

This map shows the geographic impact of Gaofeng Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gaofeng Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gaofeng Liang more than expected).

Fields of papers citing papers by Gaofeng Liang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gaofeng Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gaofeng Liang. The network helps show where Gaofeng Liang may publish in the future.

Co-authorship network of co-authors of Gaofeng Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Gaofeng Liang. A scholar is included among the top collaborators of Gaofeng Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gaofeng Liang. Gaofeng Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Lingyang, et al.. (2025). Iodine stimulated “in-situ” growth of His/GSH-AuNCs for the detection of iodine ions via ratiometric fluorescence. Microchemical Journal. 209. 112717–112717. 2 indexed citations
2.
3.
Zhu, Haifeng, et al.. (2024). Radiation-primed TGF-β trapping by engineered extracellular vesicles for targeted glioblastoma therapy. Journal of Controlled Release. 370. 821–834. 7 indexed citations
4.
Zhang, Huijun, et al.. (2024). Histone deacetylase 8 promotes innate antiviral immunity through deacetylation of RIG-I. Frontiers in Cellular and Infection Microbiology. 14. 1415695–1415695. 2 indexed citations
5.
Zhang, Zequn, et al.. (2024). Research progress in tumor therapy of carrier-free nanodrug. Biomedicine & Pharmacotherapy. 178. 117258–117258. 7 indexed citations
6.
Wang, Jin‐Tao, Kuili Liu, Qingfeng Li, et al.. (2024). Antibacterial and anti-inflammatory synergistic effects of double-layer hydrogel promoting bacterial wound healing. Chemical Engineering Journal. 493. 152513–152513. 37 indexed citations
7.
Li, Jun, et al.. (2024). Biomacromolecular hydrogel scaffolds from microfluidics for cancer therapy: A review. International Journal of Biological Macromolecules. 282(Pt 1). 136738–136738. 2 indexed citations
8.
9.
Mao, Longfei, et al.. (2024). Synthesis of compounds based on the active domain of cabotegravir and their application in inhibiting tumor cells activity. ChemistryOpen. 13(7). e202300284–e202300284. 1 indexed citations
10.
Wu, Xiangyi, et al.. (2024). Tailoring esophageal tumor spheroids on a chip with inverse opal scaffolds for drug screening. SHILAP Revista de lepidopterología. 3(3). 35402–35402.
11.
He, Jinxian, et al.. (2024). circ_0000592 facilitates the progression of esophageal squamous cell carcinoma via miR‐155‐5p/FZD5 axis. Journal of Biochemical and Molecular Toxicology. 38(6). e23742–e23742. 4 indexed citations
12.
Lin, Xiang, Lijun Cai, Min Nie, et al.. (2023). Light-activated extracellular matrix microcarriers with engineered MSCs loading for autoimmune psoriasis treatment. Chemical Engineering Journal. 470. 144118–144118. 12 indexed citations
13.
Liang, Gaofeng, et al.. (2022). Flow-through Dorsoulnar Perforator Flap Repair of Soft-Tissue Defect of the Finger with Segmental Digital Arterial Defect. Journal of College of Physicians And Surgeons Pakistan. 32(5). 685–687. 2 indexed citations
14.
Chen, Tian, et al.. (2022). Prognostic value of prognostic nutritional index and its variations in advanced non‐small‐cell lung cancer patients treated with anlotinib monotherapy. Journal of Clinical Laboratory Analysis. 36(4). e24300–e24300. 7 indexed citations
15.
Chen, Tian, Xiaoyu Xu, Gaofeng Liang, et al.. (2022). Inflammation‐based prognostic scoring system for predicting the prognosis of advanced small cell lung cancer patients receiving anlotinib monotherapy. Journal of Clinical Laboratory Analysis. 36(12). e24772–e24772. 6 indexed citations
16.
Du, Jingxia, Hongchao Li, Jingjing Song, et al.. (2022). AMPK Activation Alleviates Myocardial Ischemia-Reperfusion Injury by Regulating Drp1-Mediated Mitochondrial Dynamics. Frontiers in Pharmacology. 13. 862204–862204. 37 indexed citations
17.
Liang, Gaofeng, et al.. (2020). PTPN14, a target gene of miR‐4295, restricts the growth and invasion of osteosarcoma cells through inactivation of YAP1 signalling. Clinical and Experimental Pharmacology and Physiology. 47(7). 1301–1310. 9 indexed citations
18.
Chen, Jing, et al.. (2020). Dual HER2 Blockade in Neoadjuvant Treatment of HER2+ Breast Cancer: A Meta-Analysis and Review. Technology in Cancer Research & Treatment. 19. 1079228369–1079228369. 13 indexed citations
19.
Li, Jinghua, Yun Liu, Xiaonan Li, et al.. (2019). ROS self-generation and hypoxia self-enhanced biodegradable magnetic nanotheranostics for targeted tumor therapy. Nanoscale Horizons. 5(2). 350–358. 25 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ningning Yang Breakdown of academic impact, for papers by Xiaohui Zhu Breakdown of academic impact, for papers by Keivan Majidzadeh‐A Breakdown of academic impact, for papers by Yunsheng Xu Breakdown of academic impact, for papers by Xuan Liu Breakdown of academic impact, for papers by Zhiming Li Breakdown of academic impact, for papers by Bao‐Ting Zhang Breakdown of academic impact, for papers by Hualin Fu Breakdown of academic impact, for papers by Qilong Wang Breakdown of academic impact, for papers by Jinhua Zhou
Rankless by CCL
2026